MYOV NYSE
Myovant Sciences Ltd.
1W: +0.1%
1M: +0.3%
3M: +0.3%
1Y: +137.1%
3Y: +173.6%
5Y: +68.6%
$26.98
Last traded 2023-03-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$269M
-172.5% ▼
Capital Expenditures
$974K
+45.1% ▲
5Y CAGR: +0.1%
Free Cash Flow
-$270M
-173.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$261M
-143.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$143M | -$274M | -$289M | -$255M | -$206M |
| Depreciation & Amort. | $243K | $438K | $2M | $2M | $3M |
| Stock-Based Comp. | $12M | $19M | $40M | $54M | $39M |
| Change in Working Capital | $14M | $27M | $21M | $585M | -$107M |
| Other Non-Cash Items | $338K | $3M | -$494K | $1M | $2M |
| Operating Cash Flow | -$117M | -$224M | -$221M | $371M | -$269M |
| — Investing Activities — | |||||
| Capital Expenditures | -$604K | -$1M | -$1M | -$2M | -$974K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$32M | -$64M | -$119M |
| Investment Sales | $0 | $0 | $29M | $56M | $102M |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$604K | -$1M | -$4M | -$9M | -$18M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $46M | $274M | $146M | $238M | $26M |
| Financing Cash Flow | $46M | $274M | $146M | $238M | $26M |
| Net Change in Cash | -$72M | $49M | -$79M | $599M | -$261M |
| Cash End of Period | $109M | $157M | $78M | $677M | $417M |
| Free Cash Flow | -$118M | -$225M | -$222M | $369M | -$270M |